ライフサイエンスコーパス: HRCT

1 HRCT abnormalities, as well as their anatomical distribu

2 HRCT can distinguish between active inflammatory changes

3 HRCT can help to differentiate eosinophilic from non-eos

4 HRCT demonstrated virtually no evidence of interstitial

5 HRCT findings at BOS diagnosis after lung transplantatio

6 HRCT has a definite role in the diagnosis of COPD and ca

7 HRCT is another modality which would be useful when the

8 HRCT is used as a problem-solving tool in patients with

9 HRCT of the chest revealed multiple cavitating lung nodu

10 HRCT revealed that 76% of autoantibody-positive subjects

11 HRCT scans were blinded, randomized, and scored using th

12 HRCT scans were evaluated in a blinded manner for ground

13 HRCT scores correlated significantly with DL(CO), gas ex

14 HRCT sections involved 0.625 to 0.8-mm sections in the c

15 HRCT thorax of COVID-positive cases done during the dise

16 HRCT was performed on the 5(th) ( 1.5) day of hospitaliz

17 HRCT was scored for individual features and these featur

18 s--which were present on about 1 of every 12 HRCT scans--were associated with reduced total lung capa

19 alities were present in 194 (8%) of the 2416 HRCT scans evaluated.

20 tiple positive NTM cultures, but an abnormal HRCT was predictive of progression.

21 ntrol subjects, and correlated with abnormal HRCT scans.

22 There were no significant differences among HRCT diagnostic categories between IIP and CTD-ILD.

23 (95% confidence interval [CI], 1.7-9.2) and HRCT response by 4.9 times (95% CI, 1.9-13.0).

24 between interstitial lung abnormalities and HRCT measurements of total lung capacity and emphysema.

25 Combination of MR cisternography and HRCT appears to be complementary, accurate and non-invas

26 ve value [NPV] of both MR cisternography and HRCT together were 93%, 100%, 100% and 50% respectively.

27 In most subjects with typical clinical and HRCT features of idiopathic UIP, neither prednisone nor

28 alitative evaluation of (18)F-FDG PET/CT and HRCT perform similarly for the diagnosis of PLC, with bo

29 ographic, clinical, and laboratory data, and HRCT imaging were collected and compared between dischar

30 Their clinical features and HRCT findings were investigated to predict the risk for

31 was seen between exacerbation frequency and HRCT changes.

32 We integrated prognostic physiological and HRCT variables to form a clinical staging algorithm pred

33 ealth history and exposure questionnaire and HRCT scans, which were categorized by visual assessment

34 The threshold values of chest X-ray and HRCT quantitative parameters were calculated and were fo

35 ed from sputum or gastric lavage, as well as HRCT were performed in all children prior to administrat

36 We assessed HRCT scans from patients with IPF (n = 315) enrolled in

37 At HRCT 40 out of 44 patients with class III ranking showed

38 nges; and 4) patients who exhibited atypical HRCT changes.

39 Available HRCT scans were reviewed centrally.

40 een March and April 2020 having (a) baseline HRCT at hospital admission and (b) predominant GGOs patt

41 phosphamide [n=63]) with acceptable baseline HRCT studies and at least one outcome measure were inclu

42 everity of reticular infiltrates on baseline HRCT and the baseline MRSS as patient features that migh

43 The baseline HRCT fibrosis score is a predictor of a future decline i

44 ry and LCI in PCD and no correlation between HRCT features and LCI or spirometry in PCD.

45 al and serological profiles were assessed by HRCT and pulmonary function tests (PFTs) at baseline (Ye

46 14%) had evidence of interstitial changes by HRCT, whereas 35.2% had abnormalities on transbronchial

47 f the subjects with SSc (n = 324) had ILD by HRCT and 46% displayed pulmonary function declines consi

48 the mean airway lumenal area as measured by HRCT and the mean partial spirometric outcomes were high

49 Usual interstitial pneumonia by HRCT (P < 0.0002) and baseline quantitative fibrosis sco

50 ltiple positive NTM cultures, characteristic HRCT findings, and progression of HRCT changes should be

51 Chest HRCT QIA at CLAD onset appears promising as a method for

52 Chest HRCT scans, performed before therapy and after the concl

53 L), and 15 of these patients underwent chest HRCT.

54 ung transplant recipients at UCLA with chest HRCT performed within 90 d of CLAD onset and 47 no-CLAD

55 graphy alone and combined CT cisternography, HRCT and MR cisternography, the results were not statist

56 The most common HRCT presentation of COP was ground-glass opacity (GGO)

57 variability of HRCT findings and correlated HRCT abnormalities with physiologic measures in 57 patie

58 We correlated HRCT with spirometry, body plethysmographic lung volumes

59 a to be present on high-resolution chest CT (HRCT) or surgical lung biopsy.

60 attenuation of thoracic high-resolution CT (HRCT) abnormalities and serum markers of lung fibrosis.

61 pulmonary function, and high-resolution CT (HRCT) criteria.

62 of baseline clinical and high resolution CT (HRCT) findings in patients with severe COVID-19.

63 Background High-resolution CT (HRCT) is central to the assessment of interstitial lung

64 igate the performance of high-resolution CT (HRCT) versus (18)F-FDG PET/CT for the diagnosis of pulmo

65 eoperative (</=3 months) high resolution CT (HRCT) was performed for 118 pulmonary nodules of the ade

66 Either a bone defect on high resolution CT [HRCT] or CSF column extending extracranially from the su

67 by 2.3 times (95% CI, 1.1-5.2) but decreased HRCT response by 4.4 times (95% CI, 1.7-11.5).

68 work is to study the usage of multi-detector HRCT chest in diagnosing pulmonary TB cases whose sputum

69 In this group of diseases, HRCT findings play a fundamental role, being especially

70 A double reading was performed for each HRCT (62 observations).

71 95% CI 0.001-0.306, p = 0.013), and elevated HRCT score (OR: 1.276, 95% CI 1.002-1.625, p = 0.049) to

72 two or more characteristic findings on entry HRCT (60%, 9/15) as compared with subjects with two posi

73 dicted alveolitis in the middle lung fields, HRCT did not detect all sites of inflammation and did no

74 r longer) for culture, 60% (5.5-11.5 mo) for HRCT, and 53% (8.5 mo) for symptoms.

75 mean value of 'a posteriori probability' for HRCT was 0.6358.

76 Radiographic features from HRCT scans included ground-glass opacity, consolidation,

77 and LCI, of which a subset of 21 of each had HRCT performed.

78 as present in all of the 25 subjects who had HRCT.

79 HP is diagnosed by exposure identification, HRCT findings of ground-glass opacities, centrilobular n

80 rapy with high-dose corticosteroids improved HRCT scans and PFT results of patients with gl-ILD and a

81 of 6 of these patients (83%) having improved HRCT scan scores (P = .063).

82 -dose corticosteroids significantly improved HRCT scores and forced vital capacity.

83 litative parameters of COPD were assessed in HRCT and were correlated with PFT.

84 ntitative and qualitative indices of COPD in HRCT with PFT values, and to derive at the threshold val

85 values at baseline, presence of honeycomb in HRCT, and UIP histologic pattern were found to be predic

86 We studied the prognostic value of key HRCT features at BOS diagnosis after lung transplantatio

87 a baseline pulmonary function test and lung HRCT screening to diagnose ILD early and tailor further

88 male patients had crazy-paving on their lung HRCT (p=0.02).

89 hose smears are negative can benefit from MD HRCT chest findings to predict those patients of high ri

90 MATERIAL/METHODS: HRCT images of 35 patients (mean age: 38+/-14years; 54.3

91 MATERIAL/METHODS: HRCT scans of 31 sequential patients (mean age: 54.3+/-1

92 ed based on changes in Quantitative Modified HRCT scores and PFTs over time.

93 The main advantage of HRCT is a very detailed depiction of the lung parenchyma

94 initial interpretation and classification of HRCT findings.

95 A total of 25 patients had a combination of HRCT and MR cisternography.

96 equivocal evidence on the interpretation of HRCT features at ILD-related imaging.

97 initially focusing on the interpretation of HRCT findings may prove of considerable value provided t

98 acteristic HRCT findings, and progression of HRCT changes should be monitored closely and considered

99 and exit HRCTs (n = 6) showed progression of HRCT findings, whereas only 17% of subjects with two pos

100 o evaluate AMFM and visual quantification of HRCT patterns and their relationship with disease progre

101 ate) and specificity (true negative rate) of HRCT test were 0.8125 and 0.8571, respectively.

102 omic Classifier identified UIP regardless of HRCT pattern.

103 Reliability of HRCT scan measurements were assessed using weighted kapp

104 s the differential diagnosis and the role of HRCT in follow-up and assessment of complications.

105 To evaluate the role of HRCT in quantifying emphysema in severe COPD patients an

106 Material/Automatic lung segmentation of HRCT scans in 41 severe COPD patients (GOLD stage III or

107 ography (HRCT); however, the repeated use of HRCT is limited because of concerns regarding radiation

108 rrater reliability and construct validity of HRCT-reported nodules, ground-glass opacity, or other ty

109 Given the values of HRCT scores for both disease severity and viral clearanc

110 terobserver and intraobserver variability of HRCT findings and correlated HRCT abnormalities with phy

111 between total lung function abnormalities on HRCT and FVC (P < 0.05), and a trend towards statistical

112 e persistence of their lung abnormalities on HRCT at 18 months after infection.

113 possible UIP with traction bronchiectasis on HRCT and had not undergone surgical lung biopsy had dise

114 nce of moderate lower lobe bronchiectasis on HRCT is common in COPD and is associated with more sever

115 n of 54 patients (50%) had bronchiectasis on HRCT, most frequently in the lower lobes (18 of 54, 33.3

116 The main presentations of COP on HRCT include bilateral GGOs and consolidations in the lo

117 ponent of the disease, must be determined on HRCT, either qualitatively or quantitatively.

118 d histologic pattern and total ILD extent on HRCT, only SOFIA-PIOPED probabilities were predictive of

119 al interstitial lung disease [ILD] extent on HRCT, percent predicted FVC, Dl(CO), or the composite ph

120 nterstitial pneumonia (UIP)-like features on HRCT (UIP probability), in a large cohort of well-charac

121 The correlation between fibrosis on HRCT and the presence of alveolitis on BAL was significa

122 When stratified by baseline fibrosis on HRCT, the rate of decline in the FVC% predicted was stat

123 h-risk patients without specific findings on HRCT scans, and it is most useful in the presence of wel

124 up analysis of patients with honeycombing on HRCT and/or confirmation of UIP by biopsy versus patient

125 ib, to that of patients with honeycombing on HRCT and/or confirmation of UIP by biopsy.

126 Extent of reticulation and honeycombing on HRCT is an important independent predictor of mortality

127 pathological findings could be identified on HRCT of the lungs and no respiratory symptoms were consi

128 one was involved by reticular infiltrates on HRCT and/or whether patients exhibited an MRSS of at lea

129 A study-site diagnosis of IPF on HRCT was regularly confirmed by core radiologists.

130 milarly, while ground-glass opacification on HRCT accurately predicted alveolitis in the middle lung

131 VID) showing (a) predominant GGOs pattern on HRCT performed between August 2019 and April 2020 and (b

132 dmission and (b) predominant GGOs pattern on HRCT; a second set of 30 patients (nCOVID) showing (a) p

133 sessed the presence of signs favoring PLC on HRCT (smooth or nodular septal lines, subpleural nodular

134 inconsistent usual interstitial pneumonia on HRCT, the classifier showed 81% positive predictive valu

135 ions: Deep learning-based UIP probability on HRCT provides enhanced outcome prediction in patients wi

136 of fibrosis (QLF) and of total ILD (QILD) on HRCT.

137 interstitial lung abnormalities are seen on HRCT for a subset of patients infected with SARS-CoV-2 p

138 sing a simplified Brody II scoring system on HRCT at BOS diagnosis, in a cohort of 106 bilateral lung

139 Only HRCT imaging and pathologic fibrosis were able to reliab

140 MR cisternography, 5 patients underwent only HRCT and one patient underwent HRCT, MR cisternography a

141 e provided thorough familiarity with optimal HRCT techniques and methods of interpretation.

142 Other HRCT findings were: consolidation (63%), pulmonary nodul

143 Immunosuppressive therapy improved patients' HRCT scan scores (P < .0001), forced vital capacity (P =

144 The median values of days when the peak HRCT scores were reached in pneumonia or severe pneumoni

145 ences between pretreatment and posttreatment HRCT scan scores, pulmonary function test results, and l

146 The predominant HRCT pattern was decreased attenuation as part of a mosa

147 This study demonstrated that the predominant HRCT presentation of idiopathic PAP was interlobular sep

148 The predominant HRCT presentation of PAP was interlobular septal thicken

149 ng the study population, 108 cases presented HRCT features of active PTB and the remaining cases were

150 We then designed provisional HRCT diagnostic criteria based on the results to rank th

151 he threshold values for various quantitative HRCT indices of COPD.

152 positive likelihood ratio of class I ranking HRCT criteria to diagnose active pulmonary TB were 95%,

153 reduced airflow and infant tptef/te reduced HRCT airway caliber at age 26.Conclusions: These finding

154 the time (n = 56) and who underwent repeated HRCT scanning or PFT (n = 39) during the retrospective a

155 Due to its excellent spatial resolution, HRCT is invaluable in assessment of chronically discharg

156 Due to its better spatial resolution, HRCT is preferred in suspected intra temporal complicati

157 honeycomb in the high-resolution chest scan (HRCT), and the usual interstitial pneumonia (UIP) histol

158 A high-resolution CT scan (HRCT) was independently scored by four radiologists for

159 nd high-resolution computed tomography scan (HRCT) was obtained in survivors and compared with the on

160 The second HRCT could be obtained in 77 patients and showed that (1

161 58% difference) in patients with less severe HRCT findings and a lower MRSS at baseline.

162 severity and viral clearance, a standardised HRCT score system for COVID-19 is highly demanded.

163 This study demonstrates that HRCT has good interrater reliability and correlates with

164 ange in FEV1 and exacerbations suggests that HRCT may be a more appropriate outcome surrogate for lon

165 We show for the first time that HRCT, spirometry, and LCI have different relationships i

166 The HRCT findings and their extent in each patient were comp

167 The HRCT scans of chronic sarcoidosis patients tended to sho

168 The HRCT scores (peak) during disease course in COVID-19 pat

169 Immunosuppression improved the HRCT scan scores in patients with (P = .0078) and withou

170 Interobserver agreement for three of the HRCT abnormalities found in CBD was moderate: the K(W) f

171 lysed for sensitivity and specificity of the HRCT test.

172 e diagnosis will be based exclusively on the HRCT findings and histologic confirmation will be unnece

173 he diagnosis can be established based on the HRCT findings, thus making histologic confirmation unnec

174 On the HRCT images, airway area decreased in response to the in

175 When its culture test was positive, the HRCT test was 69.56-92.85% efficient in ascertaining pos

176 Thus, the HRCT test is considerably dependable.

177 objective and subjective density values, the HRCT-based visual density values are satisfactory.

178 We categorized these patients based on their HRCT results into four groups: 1) patients diagnosed wit

179 Thoracic HRCT images of the study population, comprising 124 pati

180 Even though HRCT findings are not always specific, there are several

181 ll thickening without emphysema according to HRCT than did asymptomatic current or former smokers.

182 These data suggest that, in addition to HRCT, BAL with lavage, differential cell counting, and c

183 chest high-resolution computed tomographic (HRCT) imaging were completed in a subset of participants

184 on, or high-resolution computed tomographic (HRCT) scan of the chest.

185 ts had high-resolution computed tomographic (HRCT) scans indicating centrilobular nodules with adjoin

186 f 2508 high-resolution computed tomographic (HRCT) scans of the lung obtained from a cohort of smoker

187 a using high resolution computed tomography (HRCT) and airflow using partial spirometry in five norma

188 Both high resolution computed tomography (HRCT) and MRI are helpful in evaluating middle ear patho

189 is on a high-resolution computed tomography (HRCT) and the results of sputum smear.

190 fied on high-resolution computed tomography (HRCT) as documented by features in local radiologists' r

191 res) on high-resolution computed tomography (HRCT) at baseline, the modified Rodnan skin thickness sc

192 ves the high-resolution computed tomography (HRCT) chest scans and/or pulmonary function test results

193 aseline high-resolution computed tomography (HRCT) data remains challenging.

194 sts and high resolution computed tomography (HRCT) diagnosis and scoring.

195 r chest high-resolution computed tomography (HRCT) examinations performed at the Radiology Unit of th

196 bnormal high-resolution computed tomography (HRCT) features and their extent in idiopathic chronic eo

197 ine the high resolution computed tomography (HRCT) features of idiopathic PAP.

198 pecific high-resolution computed tomography (HRCT) finding tipically observed in early Coronavirus di

199 between high-resolution computed tomography (HRCT) findings in chronic obstructive pulmonary disease

200 ibe the high-resolution computed tomography (HRCT) findings in this group of disease entities in corr

201 ed from High Resolution Computed Tomography (HRCT) images of grapevine (Vitis vinifera cv. 'Chardonna

202 role of high-resolution computed tomography (HRCT) in the prediction of presence and severity of chro

203 High-resolution computed tomography (HRCT) is an integral aspect of the evaluation of patient

204 lthough high resolution computed tomography (HRCT) is commonly used to assess interstitial lung disea

205 IPF on high-resolution computed tomography (HRCT) is key in the process of multidisciplinary diagnos

206 High-resolution computed tomography (HRCT) is the imaging method of choice for the evaluation

207 High-resolution computed tomography (HRCT) is the imaging method of choice for the evaluation

208 High-resolution computed tomography (HRCT) is the imaging technique of choice for the evaluat

209 try and high-resolution computed tomography (HRCT) lung imaging.

210 of the high-resolution computed tomography (HRCT) modality for the diagnosis of PTB, in comparison t

211 , using high-resolution computed tomography (HRCT) of the chest and a separation of diffusing capacit

212 lity of high-resolution computed tomography (HRCT) of the chest, in comparison with bronchoalveolar l

213 EV1 and high-resolution computed tomography (HRCT) of the chest.

214 f chest high-resolution computed tomography (HRCT) often delay definitive diagnosis of these infectio

215 alue of high-resolution computed tomography (HRCT) patterns and pulmonary function tests, including t

216 ognizes high-resolution computed tomography (HRCT) patterns.

217 d chest high-resolution computed tomography (HRCT) scan, and approximately 4 years later, the evaluat

218 y high-resolution chest computed tomography (HRCT) scan, was determined in patients with TSC without

219 d high-resolution chest computed tomography (HRCT) scanning in an ongoing cohort study; 72 consented

220 ties in high-resolution computed tomography (HRCT) scanning.

221 ILA) on high-resolution computed tomography (HRCT) scans and to determine progression toward clinical

222 ings on high resolution computed tomography (HRCT) scans in patients with COP.

223 Lung high-resolution computed tomography (HRCT) scans were available for fibrosis quantification a

224 ured by high-resolution computed tomography (HRCT) scans, and pulmonary function test (PFT) results.

225 ed upon high resolution computed tomography (HRCT) scans.

226 aphs or high-resolution computed tomography (HRCT) scans.

227 High-resolution computed tomography (HRCT) studies are now almost always obtained for patient

228 we used high-resolution computed tomography (HRCT) to examine the ability of a DI to distend the airw

229 osis on high-resolution computed tomography (HRCT) were performed, and interactions between disease s

230 ulture, high-resolution computed tomography (HRCT), and symptoms were assessed.

231 such as high-resolution computed tomography (HRCT), hyperpolarized (129)Xe MRI, and optical coherence

232 r chest high-resolution computed tomography (HRCT)-based computer-aided quantification of both inters

233 d using high-resolution computed tomography (HRCT).

234 ea with high resolution computed tomography (HRCT).

235 able on high-resolution computed tomography (HRCT).

236 tion on high-resolution computed tomography (HRCT).

237 IP), on high-resolution computed tomography (HRCT).

238 y high-resolution chest computed tomography (HRCT); however, the repeated use of HRCT is limited beca

239 either high-resolution computed tomography (HRCT, n = 25) or open-lung biopsy (OLB, n = 1) patterns

240 O], and high-resolution computed tomography [HRCT] of the lungs) from a prospective 3.5-year observat

241 e staging system integrating the CPI and two HRCT variables.

242 c disease; 3) patients who exhibited typical HRCT changes; and 4) patients who exhibited atypical HRC

243 azathioprine, and N-acetylcysteine underwent HRCT at study start and finish.

244 nderwent only HRCT and one patient underwent HRCT, MR cisternography and CT cisternography.

245 g, 50.5 [33.5] smoking pack-years) underwent HRCT scans of the chest to quantify the presence and ext

246 fferences between the baseline and follow-up HRCT scans and PFT were analyzed.

247 een the onset of pneumonia and the follow-up HRCT was 20.34 months.

248 uate study time to complete 5-year follow-up HRCT, the proportion with ILD events (endpoint met or ra

249 We performed this study to validate HRCT, a proposed surrogate outcome measure for CF lung d

250 values on inspiration and expiration, visual HRCT scores, and pulmonary function tests were obtained.

251 the Envisia Genomic Classifier combined with HRCT and clinical factors in a multidisciplinary discuss

252 In conjunction with HRCT patterns of UIP, the Envisia Classifier results ide

253 c characteristic most highly correlated with HRCT findings.

254 Though PPV was 100% in the groups with HRCT alone, MR cisternography alone and combined CT cist

255 and link deficits at birth in tptef/te with HRCT-assessed structural airway abnormalities in adult l